Attached files
| file | filename |
|---|---|
| EX-99.1 - MARIMED INC. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 7, 2018
| MARIMED INC. |
| (Exact name of registrant as specified in its charter) |
| Delaware | 0-54433 | 27-4672745 | ||
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) |
| 10 Oceana Way, Norwood, Massachusetts | 02062 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (617) 795-5140
26 Ossipee Road, Newton, Massachusetts 02464
(Former address of principal executive offices)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 8.01. Other Events.
On November 7, 2018, we issued a press release announcing (i) the hiring of Charles Finnie as Chief Strategy Officer, and (ii) the plan to implement a new strategic initiative designed to increase revenues.
A copy of such release is annexed hereto as an exhibit.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
| Exhibit | Description | ||
| 99.1 | November 7, 2018 Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MARIMED INC. | ||
| Dated: November 7, 2018 | ||
| By: | /s/ ROBERT FIREMAN | |
| Robert Fireman, CEO | ||
EXHIBIT INDEX
| Exhibit | Description | ||
| 99.1 | November 7, 2018 Press Release |